MENU
+Compare
MBCOF
Stock ticker: OTC
AS OF
Aug 8 closing price
Price
$0.13
Change
-$0.01 (-7.14%)
Capitalization
6.94M

MBCOF MARVEL BIOSCIENCES CORP. Forecast, Technical & Fundamental Analysis

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug... Show more

MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MBCOF with price predictions
Aug 08, 2025

MBCOF in -8.19% downward trend, falling for three consecutive days on August 06, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MBCOF declined for three days, in of 12 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MBCOF moved out of overbought territory on July 17, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator moved out of overbought territory. In of the 12 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

MBCOF broke above its upper Bollinger Band on July 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 01, 2025. You may want to consider a long position or call options on MBCOF as a result. In of 25 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MBCOF just turned positive on August 07, 2025. Looking at past instances where MBCOF's MACD turned positive, the stock continued to rise in of 15 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MBCOF advanced for three days, in of 6 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 43 cases where MBCOF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.712). P/E Ratio (0.000) is within average values for comparable stocks, (55.605). MBCOF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.011). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (287.742).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MBCOF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MBCOF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MBCOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
505 - 8th Avenue SW
Phone
+1 403 770-2467
Employees
N/A
Web
https://www.marvelbiotechnology.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGEN8.710.77
+9.70%
FibroGen Inc
LMND48.981.72
+3.64%
Lemonade
CTAS226.272.87
+1.28%
Cintas Corp
FLO16.350.09
+0.55%
Flowers Foods
IRBT3.75-0.16
-4.09%
iRobot Corp

MBCOF and Stocks

Correlation & Price change

A.I.dvisor tells us that MBCOF and XENE have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MBCOF and XENE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBCOF
1D Price
Change %
MBCOF100%
-1.81%
XENE - MBCOF
20%
Poorly correlated
-0.59%
BSFAF - MBCOF
8%
Poorly correlated
N/A
ZEOX - MBCOF
6%
Poorly correlated
-7.04%
ATYR - MBCOF
5%
Poorly correlated
+1.15%
LENZ - MBCOF
3%
Poorly correlated
+7.97%
More